Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)

YTD

ALL

Why Robinhood?

You can watch AST+ and buy or sell other stocks, ETFs, and their options commission-free!

About AST+

Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer.

CEO

Brian M. Culley, MBA

CEOBrian M. Culley, MBA

Employees

—

Employees—

Headquarters

Carlsbad, California

HeadquartersCarlsbad, California

Founded

2012

Founded2012

Employees

—

Employees—

AST+ Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.